Levin, Dimitriy <br/><br/>
Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.  [electronic resource] 

 -  Archives of neurology  Jan 2011 
 - 135; author reply 135-6 p.  digital 
<br/><br/> Publication Type: Comment; Letter; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-3687 
<br/><br/><label>Standard No.: </label>10.1001/archneurol.2010.323  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cerebral Hemorrhage--chemically induced<br/>Humans<br/>Injections, Intravenous<br/>Risk Factors<br/>Thrombolytic Therapy<br/>Tissue Plasminogen Activator--administration & dosage<br/>Warfarin--administration & dosage